As shown in Figure 2A and 2B, we found that combined treatment with Cat GI plus TRAIL increased apoptosis population and PARP cleavage in renal carcinoma cells (ACHN and A498), lung cancer cells (A549) and cervical cancer cells (HeLa). This evidence concerns the gene TNFSF10 and lung cancer.